SpaceX’s S-1 registration statement, filed with the SEC ahead of a planned June 12 initial public offering at a $1.75 trillion valuation, reveals a multifront push into healthcare spanning rural hospital connectivity, telemedicine and AI-assisted clinical care.
“Connectivity infrastructure in space is designed to help everyone on Earth have access to education, healthcare, entertainment, and communications, and to enable people to overcome many traditional limits, such as physical and political borders,” the company wrote.
Here are five things health system leaders should know about Elon Musk’s SpaceX:
1. Starlink explicitly targets hospitals and telemedicine. The prospectus states that satellite internet service’s global reach has the potential to provide essential connectivity to rural hospitals and calls out “telemedicine for hard-to-reach patients” as a supported application. As of March 31, the service had approximately 10.3 million subscribers across 164 countries, with rural and underserved communities as a stated priority.
2. The financials are opaque on healthcare. SpaceX reported $18.67 billion in 2025 revenue and a $4.94 billion net loss but does not break out healthcare-specific figures. The Connectivity segment — home to Starlink — was the clear profit driver, generating $4.42 billion in operating income last year on $11.39 billion in revenue.
3. Orbital drug manufacturing is an identified future market. The S-1 lists in-orbit pharmaceutical manufacturing among SpaceX’s future market opportunities and defines microgravity as enabling “unique manufacturing processes like creating ultra-pure materials.”
4. The prospectus pitches AI for clinical diagnosis. SpaceX states in the filing that AI systems can “aid healthcare professionals in precise medical analysis and diagnosis.” The company’s xAI Gov product provides its Grok AI to government agencies — though Grok drew scrutiny earlier in 2026 when HHS deployed it on the nutrition website realfood.gov and it hallucinated medical studies and contradicted agency guidance, Forbes reported.
5. SpaceX is already selling compute to Anthropic. The S-1 discloses that SpaceX entered cloud services agreements with Anthropic in May, providing approximately 325,000 NVIDIA GPUs at $1.25 billion per month through May 2029 — a deal that puts SpaceX infrastructure at the center of one of healthcare AI’s most active developers.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.